Skip to main content
. 2017 May 24;8(46):81285–81294. doi: 10.18632/oncotarget.18150

Table 1. Demographic characteristics of patients.

Characteristics FK506 CsA
GG AA/AG GG AA/AG
Patient, n (AA/AG) 65 58 (11/47) 52 43 (9/34)
Gender, M/F 45/20 32/26 33/19 30/13
Age, mean±sd, years 39.18±10.79b 39.24±10.34 46.10±11.41 41.56±11.48
Weight, mean±sd, kg 56.39±10.74 55.04±8.42 58.58±8.90 57.76±9.62
HLA mismatch, mean±sd 2.98±1.20 2.76±1.44 2.81±1.57 2.67±1.54
Cause of kidney disease, n
 Glomerular disease 59 51 48 40
 Gouty nephropathy 1 1 0 0
 Polycystic kidney disease 2 2 0 1
 Others 3 4 4 2

b: p < 0.01 vs CYP3A5*GG with CsA treatment.